MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup AnalysisPaul G. Richardson, Joan Bladé, Michèle Cavo et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 1
Poster: MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup AnalysisPaul G. Richardson, Joan Bladé, María‐Victoria Mateos et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 0